BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 19442921)

  • 1. Hepatitis vaccination and prophylaxis.
    Nguyen CT; Tran TT
    Clin Liver Dis; 2009 May; 13(2):317-29. PubMed ID: 19442921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with hepatitis A and B vaccines.
    Davis JP
    Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis vaccination of adults].
    Jost R
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1104-9. PubMed ID: 9691345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
    Keystone JS; Hershey JH
    Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men.
    Kahn J
    Clin Infect Dis; 2002 Dec; 35(11):1382-7. PubMed ID: 12439802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preventive vaccination for viral hepatitis].
    Jilg W
    Z Gastroenterol; 1997 Jul; 35(7):585-90. PubMed ID: 9340933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination against hepatitis A and B in HCV-infected patient?].
    Blum E
    Internist (Berl); 1998 Sep; 39(9):980. PubMed ID: 9788121
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension.
    Rosa MN; Hessel G; Alves De Tommaso AM
    Acta Gastroenterol Latinoam; 2008 Sep; 38(3):187-93. PubMed ID: 18979898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive and active immunoprophylaxis of hepatitis B.
    Seeff LB; Koff RS
    Gastroenterology; 1984 May; 86(5 Pt 1):958-81. PubMed ID: 6231210
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations for protection against viral hepatitis. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1985 Sep; 103(3):391-402. PubMed ID: 3161440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities?
    Hernandez B; Hasson NK; Cheung R
    Am J Gastroenterol; 2009 Aug; 104(8):1961-7. PubMed ID: 19491840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge, attitudes and barriers regarding vaccination against hepatitis A and B in patients with chronic hepatitis C virus infection: a survey of family medicine and internal medicine physicians in the United States.
    Tenner CT; Herzog K; Chaudhari S; Bini EJ; Weinshel EH
    Int J Clin Pract; 2012 Oct; 66(10):1009-13. PubMed ID: 22994334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
    Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
    Chen H; Cantrell CR
    Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
    Beran J
    Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.
    Campbell JV; Garfein RS; Thiede H; Hagan H; Ouellet LJ; Golub ET; Hudson SM; Ompad DC; Weinbaum C;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S64-72. PubMed ID: 17276018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention.
    Can Commun Dis Rep; 1997 Sep; 23():1-6. PubMed ID: 9327646
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of anti-HAV antibodies in Warsaw population].
    Janaszek-Seydlitz W; Bucholc B; Wiatrzyk A
    Przegl Epidemiol; 2007; 61(4):675-82. PubMed ID: 18572499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunization against viral hepatitis: an obligatory recommendation in consults for sexually transmitted diseases].
    García-Doval I
    Actas Dermosifiliogr; 2007 Mar; 98(2):88-90. PubMed ID: 17397593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.